SCHEMBL6152934

SCHEMBL6152934

CCCCc1ccc(-c2c[nH]c(-c3ccc(CCCC)cc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR84 Q9NQS5 2/20 0.50
RARB P10826 6/20 0.47
CTSV O60911 2/20 0.47
CTSL P07711 2/20 0.47
NISCH Q9Y2I1 1/20 0.43
TSHR P16473 2/20 0.42
HSD17B10 Q99714 1/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
TP53 P04637 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
MAPT P10636 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
RARA P10276 1/20 0.41
MTOR P42345 1/20 0.41
KMT2A Q03164 1/20 0.41
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
HSD11B1 P28845 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19664334 0.94 HSD11B1 (0.50) GPR84RARBCTSVCTSLMAPT
SCHEMBL6152767 0.93 HSD17B10 (0.51) GPR84RARBCTSVCTSLTSHR
SCHEMBL17280169 0.91 PTPN1 (0.44) GPR84RARBCTSVCTSLNISCH
SCHEMBL25431049 0.87 HSD17B10 (0.46) GPR84RARBCTSVCTSLTSHR
SCHEMBL17280175 0.80 NPC1 (0.45) GPR84CTSVCTSLNISCHNPC1
SCHEMBL5551587 0.79 RARB (0.67) RARBNISCHTSHRHSD17B10NPC1
SCHEMBL28829434 0.79 RARB (0.67) RARBNISCHTSHRHSD17B10NPC1
SCHEMBL23319637 0.77 RARB (0.60) GPR84RARBNISCHTSHRHSD17B10
SCHEMBL28900119 0.77 RARB (0.64) RARBNISCHTSHRHSD17B10NPC1
SCHEMBL28457816 0.76 HSD11B1 (0.44) GPR84RARBCTSVCTSLHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1253151-B1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES (JP) 2005-01-12 EP disclosed
US-6805978-B2 COMPLEX CONTAINING DIKETOPYRROLO(3,4-C)PYRROLE COMPOUND TORAY INDUSTRIES, INC. (JP) 2004-10-19 US disclosed
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound TORAY INDUSTRIES, INC. (JP) 2003-05-01 US disclosed
EP-1253151-A1 Pyrromethene metal complex and light emitting device composition and light emitting devices using the same TORAY INDUSTRIES, INC. (JP) 2002-10-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082406-A1 Complex containing diketopyrrolo(3,4-c)pyrrole compound PPOX, CPNE4, TP53RK GPR84 2529/4885RARB 2079/4885CTSV 2058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.